*0011298624
*008200810s2019    xx#           000 0 nob
*019  $bk
*08230$a338.76161519
*100  $aSveen, kari$4aut$_134275500
*245  $aKlinisk legemiddelforskning i Nyco/GE Healthcare i 50 år
*300  $aS. 5-19 : ill., port.
*520  $aEngelsk sammendrag
*610  $aGE Healthcare Norge$_152173200
*610  $aNycomed$_131555100
*610  $aNyegaard & Co. (Nyco)$_152173300
*650  $alegemiddelfirmaer$9nor$2norart$_130627800
*650  $alegemiddelforskning$9nor$2norart$_133880300
*650  $alegemiddelutvikling$9nor$2norart$_131546000
*700  $aAndrew, Erik;$4aut$_152173400
*700  $aGordon, Paul$4aut$_127143900
*773  $tCygnus$gH. 26 (2019)$x0809-4039$w(NO-LaBS)2594(tnr)
*8564 $uhttp://norskfarmasihistorie.no/cygnus/
*999  $z2000653058$anorart:2000653058
^